查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1716771

不孕症治療市場（按產品類型、治療類型、診斷方法、最終用戶分類）—2025 年至 2030 年全球預測

Infertility Treatment Market by Product Type, Treatment Type, Diagnosis, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

不孕症治療市場預計在 2024 年將達到 59.3 億美元，在 2025 年將達到 65.8 億美元，到 2030 年將達到 113 億美元，複合年成長率為 11.32%。

主要市場統計數據
基準年2024年 59.3億美元
預計2025年 65.8億美元
預測年份 2030 113億美元
複合年成長率（%） 11.32%

在醫學快速發展的今天，不孕症治療已經成為無數個人和家庭的一線希望。隨著尖端技術創新和患者照護標準的不斷提高，這個市場不僅規模不斷成長，而且複雜性也在不斷演變。在過去的幾年裡，新技術與對生殖醫學的更深入理解相結合，改變了診斷和治療實踐。這種轉變體現在微創手術的日益普及、檢查技術的最佳化以及監測工具的增強，這些都顯著提高了治療週期的成功率。

全球對個人化和改善患者體驗的關注導致了解決不孕症問題的更全面的方法。醫療保健提供者和研究人員正在不斷探索將傳統方法與新的科學發現相結合的綜合治療途徑，從而提高療效並減輕患者的心理和經濟負擔。本執行摘要確定了主要的市場趨勢，概述了主要的細分發現，並提供了一系列可行的建議以進一步探索這一充滿活力的領域。

重新定義生育治療的變革性轉變

近年來，不孕症治療的環境發生了巨大變化。診斷影像系統和雷射設備等領域的技術引入為更準確的診斷和有針對性的干涉鋪平了道路。現代低溫系統和先進的培養箱設計徹底改變了保存過程，確保了後續治療週期的更高成功率。這些進步是由對以患者為中心的護理的日益重視所推動的，臨床醫生青睞於能夠最大程度減少不適並加快恢復時間的技術。

此外，法律規範和增加的研究資金正在加速創新治療方法的採用。隨著新技術融入常規臨床實踐，我們正在見證向高度專業化的診斷工具和治療方法的轉變。這種轉變不僅提高了患者照護的質量，也改變了產業內的競爭態勢。決策者現在發現自己正處於擁抱技術進步和確保卓越營運的十字路口，因此他們必須在策略上適應當前的市場需求。

塑造市場的詳細細分洞察

對市場的詳細評估揭示了清晰的細分模式，推動了不孕症治療產業的策略決策。根據產品類型，我們專注於配件、設備以及介質和消耗品。具體來說，設備部分對低溫系統、氣體分析儀、成像系統、培養箱、雷射系統、微操作系統、顯微鏡、卵子抽吸泵、精子分析儀系統和精子分離器進行了全面而詳細的回顧。此外，冷凍保存和培養基等培養基和消耗品在治療過程中保持高品質和活力方面發揮著至關重要的作用。

根據治療類型進行細分可以揭示更多見解。市場分析主要關注子宮頸內、子宮內和子宮內方法的人工授精，這些方法已經被特別研究。輔助生殖技術 (ART) 包括胚胎冷凍保存、體外受精 (IVF)、卵細胞質內單一精蟲顯微注射術(ICSI) 和胚胎著床前基因診斷 (PGD)。同樣，不孕症治療包括針對性不孕症藥物，如克羅米芬檸檬酸鹽、促性腺激素分泌、來曲唑和Metformin，以及節育手術，如子子宮鏡檢查、腹腔鏡檢查、肌瘤切除術、子宮腫塊修復術和子宮切除術。進一步基於診斷的細分區分了女性不孕症（透過造影和排卵測試進行評估）和男性不孕症（透過血液檢查、精液分析和睪丸切片檢查進行評估）之間的細微差別，最終用戶包括冷凍庫、不孕症診所、醫院和研究機構。這個全面的細分框架為市場理解和策略規劃提供了堅實的基礎。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 生活型態改變和生育延遲導致不孕不育率上升
      • 增加生育治療研發的投資和資金
      • 提高對輔助生殖技術的認知與接受度
    • 限制因素
      • 生育治療費用高昂，且治療通訊協定多變
    • 機會
      • 推動個人化醫療方法，根據個別患者的生育狀況量身定做
      • 引入遠端醫療，擴大生育諮詢和治療的機會
    • 任務
      • 缺乏對生育治療的認知與教育
  • 市場區隔分析
    • 產品類型：設備在生育治療的重要性日益增加
    • 最終使用者：全面的生育治療增加了人們對生育診所的興趣。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章 生育治療市場（依產品類型）

  • 配件
  • 裝置
    • 低溫系統
    • 氣體分析儀
    • 影像系統
    • 培養箱
    • 雷射系統
    • 微作業系統
    • 顯微鏡
    • 卵子吸泵
    • 精子分析系統
    • 精子分離器
  • 介質和耗材
    • 冷凍保存培養基
    • 文化傳媒

第7章 不孕症治療市場（依治療類型）

  • 人工授精
    • 子宮頸內授精
    • 輸卵管內授精
    • 子宮腔內授精
  • 輔助生殖技術（ART）
    • 胚胎冷凍保存
    • 體外受精（IVF）
    • 卵細胞質內單一精蟲顯微注射術（ICSI）
    • 胚胎著床前基因診斷（PGD）
  • 生育藥物
    • 克羅米芬檸檬酸鹽
    • 促性腺激素分泌
    • 來曲唑
    • Metformin
  • 不孕不育治療手術
    • 子宮鏡檢查
    • 腹腔鏡檢查
    • 子宮肌瘤切除術
    • 靜脈曲張修復
    • 靜脈曲張切除術

第8章 不孕症治療市場（依診斷）

  • 女性不孕症
    • 造影（HSG）
    • 排卵測試
  • 男性不孕
    • 血液檢查
    • 精子分析
    • 切片檢查

第9章不孕症治療市場（依最終使用者）

  • 精子庫
  • 不孕不育診所
  • 醫院
  • 研究機構

第10章美洲的生育治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太生育治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲生育治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • AbbVie Inc.
  • Bayer AG
  • City Fertility Centre
  • CooperSurgical, Inc.
  • Cryoport Systems, LLC.
  • Embryolab
  • EQUIPO IVI, SL
  • Ferring International Center SA
  • FUJIFILM Irvine Scientific, Inc.
  • Genea Group
  • IVI AMERICA, LLC
  • Merck KGaA
  • Monash IVF
  • New Hope Fertility Clinic
  • Nova IVF Fertility
  • NOW-fertility SA
  • Ovum Woman and Child specialty Hospital
  • ReproTech LLC
  • Seegene, Inc.
  • TMRW Life Sciences, Inc.
  • Vitrolife Sweden AB
Product Code: MRR-3E32260F8122

The Infertility Treatment Market was valued at USD 5.93 billion in 2024 and is projected to grow to USD 6.58 billion in 2025, with a CAGR of 11.32%, reaching USD 11.30 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 5.93 billion
Estimated Year [2025] USD 6.58 billion
Forecast Year [2030] USD 11.30 billion
CAGR (%) 11.32%

In today's rapidly advancing medical field, infertility treatment has emerged as a beacon of hope for countless individuals and families. The market is not just expanding in terms of size, but also evolving in complexity due to cutting-edge innovations and enhanced patient care standards. Over the past several years, the convergence of new technologies and a deeper understanding of reproductive health has transformed diagnostic and treatment practices. This transformation is evident in the increased adoption of minimally invasive procedures, optimized laboratory techniques, and enhanced monitoring tools that have significantly boosted success rates in treatment cycles.

The global focus on personalization and improved patient experiences has led to a more holistic approach in addressing infertility. Health care providers and researchers are continually exploring integrated treatment pathways that combine traditional methods with novel scientific discoveries, resulting in increased efficacy and reduced emotional as well as financial burdens for patients. As we delve further, this executive summary highlights critical market trends, outlines key segmentation findings, and presents actionable recommendations that collectively bring clarity to this dynamic sector.

Transformative Shifts Redefining Infertility Treatment

Recent years have witnessed transformative shifts that are reshaping the infertility treatment landscape. Technological adoption in areas such as imaging systems and laser equipment has paved the way for more precise diagnostics and targeted interventions. Modern cryosystems and advanced incubator designs have revolutionized the preservation processes, ensuring higher success rates during subsequent treatment cycles. Such advancements have been bolstered by a greater emphasis on patient-centric care, with clinicians favoring techniques that minimize discomfort and shorten recovery times.

Furthermore, regulatory frameworks and increased funding for research have accelerated the adoption of innovative treatment approaches. As emerging technologies integrate into routine clinical practice, there is a visible transition toward highly specialized diagnostic tools and therapies. This shift is not only elevating the quality of patient care but also triggering competitive dynamic changes within the industry. Decision-makers now find themselves at the crossroads of embracing technological evolution while ensuring operational excellence, making it imperative to adapt strategically to the current market demands.

In-depth Segmentation Insights Shaping the Market

A closer assessment of the market reveals clear segmentation patterns that drive strategic decision-making in the infertility treatment industry. When examining the product type, the focus is placed on Accessories, Equipment, and Media & Consumables. Equipment, in particular, has been studied in comprehensive detail, with special attention given to Cryosystems, Gas Analyzers, Imaging Systems, Incubators, Laser Systems, Micromanipulator Systems, Microscopes, Ovum Aspiration Pumps, Sperm Analyzer Systems, and Sperm Separation Devices. Additionally, Media & Consumables such as Cryopreservation Media and Culture Media play a pivotal role in maintaining high quality and viability during treatment procedures.

Segmentation based on treatment type uncovers further granular insights. The market analysis explores Artificial Insemination with its specifically studied Intracervical, Intratubal, and Intrauterine methods. Assisted Reproductive Technology (ART) is examined through the lenses of Embryo Cryopreservation, In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Preimplantation Genetic Diagnosis (PGD). Equally, fertility treatments include targeted fertility drugs, comprising Clomiphene Citrate, Gonadotropins, Letrozole, and Metformin, as well as fertility surgeries such as Hysteroscopy, Laparoscopy, Myomectomy, Varicocele Repair, and Varicocelectomy. Further segmentation based on diagnosis distinguishes the subtle differences between Female Infertility, evaluated through Hysterosalpingography and Ovulation Testing, and Male Infertility, assessed with Blood Tests, Semen Analysis, and Testicular Biopsy, while the end user spectrum covers Cryobanks, Fertility Clinics, Hospitals, and Research Institutes. This comprehensive segmentation framework provides a robust basis for market understanding and strategic planning.

Based on Product Type, market is studied across Accessories, Equipment, and Media & Consumables. The Equipment is further studied across Cryosystems, Gas Analyzers, Imaging Systems, Incubators, Laser Systems, Micromanipulator Systems, Microscopes, Ovum Aspiration Pumps, Sperm Analyzer Systems, and Sperm Separation Devices. The Media & Consumables is further studied across Cryopreservation Media and Culture Media.

Based on Treatment Type, market is studied across Artificial Insemination, Assisted Reproductive Technology (ART), Fertility Drugs, and Fertility Surgeries. The Artificial Insemination is further studied across Intracervical Insemination, Intratubal Insemination, and Intrauterine Insemination. The Assisted Reproductive Technology (ART) is further studied across Embryo Cryopreservation, In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Preimplantation Genetic Diagnosis (PGD). The Fertility Drugs is further studied across Clomiphene Citrate, Gonadotropins, Letrozole, and Metformin. The Fertility Surgeries is further studied across Hysteroscopy, Laparoscopy, Myomectomy, Varicocele Repair, and Varicocelectomy.

Based on Diagnosis, market is studied across Female Infertility and Male Infertility. The Female Infertility is further studied across Hysterosalpingography (HSG) and Ovulation Testing. The Male Infertility is further studied across Blood Tests, Semen Analysis, and Testicular Biopsy.

Based on End User, market is studied across Cryobanks, Fertility Clinics, Hospitals, and Research Institutes.

Key Regional Insights Across Diverse Global Markets

The global infertility treatment market is characterized by remarkable regional diversity, with variations in market maturity, technological readiness, and regulatory support across different territories. In the Americas, robust healthcare infrastructures and a strong emphasis on research innovation have led to early adoption of technologies and advanced treatment protocols, facilitating enhanced patient outcomes. Across Europe, Middle East & Africa, a blend of legacy medical practices and modern breakthroughs creates an ecosystem that values both traditional empathy and high-end technological contributions to infertility care.

In the Asia-Pacific region, accelerated economic development and increasing awareness of reproductive health issues have spurred significant investments in state-of-the-art facilities and treatment centers. This region is witnessing not only rapid growth in patient numbers but also the emergence of local players who are keen to implement innovative methodologies. These regional insights emphasize the importance of localized strategies that consider cultural nuances, economic variables, and infrastructural variations, enabling market players to tailor their offerings and optimize operational effectiveness on both a macro and micro level across the global landscape.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape and Key Company Insights

The competitive dynamics in the infertility treatment market are defined by the presence of several leading and influential companies that drive innovation and set industry benchmarks. Major players such as AbbVie Inc. and Bayer AG are forging ahead by investing in research and development, helping to pioneer cutting-edge treatment methodologies. Specialized institutions like City Fertility Centre and CooperSurgical, Inc. provide customized solutions that cater to diverse patient needs and clinical requirements. Innovative firms such as Cryoport Systems, LLC. and Embryolab, along with EQUIPO IVI, S. L., are continuously refining technologies that enhance operational efficiency and treatment accuracy.

Ferring International Center S.A. and FUJIFILM Irvine Scientific, Inc. further contribute to the competitive landscape with robust portfolios that encompass state-of-the-art equipment and consumables. Companies including Genea Group, IVI AMERICA, LLC, and Merck KGaA have established themselves as thought leaders by integrating advanced research into clinical applications. Notably, specialized clinics and institutes like Monash IVF, New Hope Fertility Clinic, Nova IVF Fertility, and NOW-fertility SA, along with dedicated healthcare providers such as Ovum Woman and Child Specialty Hospital, ReproTech LLC, Seegene, Inc., TMRW Life Sciences, Inc., and Vitrolife Sweden AB, continue to shape the market intricately through comprehensive, patient-focused solutions. Their contributions not only drive innovation but also set a high standard for clinical excellence and service delivery.

The report delves into recent significant developments in the Infertility Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Bayer AG, City Fertility Centre, CooperSurgical, Inc., Cryoport Systems, LLC., Embryolab, EQUIPO IVI, S. L., Ferring International Center S.A., FUJIFILM Irvine Scientific, Inc., Genea Group, IVI AMERICA, LLC, Merck KGaA, Monash IVF, New Hope Fertility Clinic, Nova IVF Fertility, NOW-fertility SA, Ovum Woman and Child specialty Hospital, ReproTech LLC, Seegene, Inc., TMRW Life Sciences, Inc., and Vitrolife Sweden AB. Actionable Recommendations for Industry Leaders

For industry leaders navigating the challenging but promising infertility treatment landscape, several key recommendations emerge from the analysis. First, continually invest in research and development initiatives to keep pace with advancing technologies and evolving clinical methods. Emphasis should be placed on integrating comprehensive diagnostic systems and ensuring that treatment processes remain patient-centric. Leaders are encouraged to form strategic alliances with technology providers and research institutions as a way to harness cutting-edge innovations while mitigating risks associated with rapid technological changes.

It is crucial to adopt a multi-faceted market approach that considers diverse segmentation factors-from product types and treatment modalities to diagnostic tools and end user needs. Firms should undertake regular competitive benchmarking to align their portfolios with global best practices, while also adapting to regional market dynamics. Enhancing regulatory compliance and focusing on operational efficiency will serve as catalysts for sustained growth. By proactively addressing new market challenges and capitalizing on emerging opportunities, industry leaders can solidify their position and drive long-term value in this evolving sector.

Conclusion and Future Outlook for Infertility Treatment

In conclusion, the infertility treatment market is undergoing a period of significant transformation. The interplay of innovative technologies, targeted segmentation strategies, and rapid regional growth presents abundant opportunities and challenges alike. As advancements in diagnostic and treatment methods continue to evolve, stakeholders must maintain agility and adaptability in order to remain competitive. The depth of segmentation based on product type, treatment type, diagnosis, and end user affirm the complexity of the market, while also highlighting key areas for strategic focus and growth.

Looking forward, an integrated approach that combines technological innovation with strategic market positioning is critical. Insights derived from both regional trends and competitive analyses offer invaluable guidance for shaping the future trajectory of infertility treatment. By embracing new methodologies and fostering collaborative partnerships, the industry can continue to enhance patient outcomes, improve technological adoption, and ultimately deliver more effective and comprehensive care solutions. The roadmap outlined herein serves as a foundation for sustained progress and market leadership in the evolving global healthcare landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of infertility due to lifestyle changes and delayed parenthood
      • 5.1.1.2. Rising investments and funding in infertility treatment research and development
      • 5.1.1.3. Increasing awareness and acceptance of assisted reproductive technologies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with infertility treatments and variability in infertility treatment protocols
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement of personalized medicine approaches tailored to individual patient fertility profiles
      • 5.1.3.2. Telemedicine implementation to expand infertility consultations and treatment accessibility
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness and education about infertility treatment
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Rising significance of equipment in infertility treatment
    • 5.2.2. End User: Growing preference for fertility clinics due to its comprehensive range of infertility treatments
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Infertility Treatment Market, by Product Type

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. Equipment
    • 6.3.1. Cryosystems
    • 6.3.2. Gas Analyzers
    • 6.3.3. Imaging Systems
    • 6.3.4. Incubators
    • 6.3.5. Laser Systems
    • 6.3.6. Micromanipulator Systems
    • 6.3.7. Microscopes
    • 6.3.8. Ovum Aspiration Pumps
    • 6.3.9. Sperm Analyzer Systems
    • 6.3.10. Sperm Separation Devices
  • 6.4. Media & Consumables
    • 6.4.1. Cryopreservation Media
    • 6.4.2. Culture Media

7. Infertility Treatment Market, by Treatment Type

  • 7.1. Introduction
  • 7.2. Artificial Insemination
    • 7.2.1. Intracervical Insemination
    • 7.2.2. Intratubal Insemination
    • 7.2.3. Intrauterine Insemination
  • 7.3. Assisted Reproductive Technology (ART)
    • 7.3.1. Embryo Cryopreservation
    • 7.3.2. In Vitro Fertilization (IVF)
    • 7.3.3. Intracytoplasmic Sperm Injection (ICSI)
    • 7.3.4. Preimplantation Genetic Diagnosis (PGD)
  • 7.4. Fertility Drugs
    • 7.4.1. Clomiphene Citrate
    • 7.4.2. Gonadotropins
    • 7.4.3. Letrozole
    • 7.4.4. Metformin
  • 7.5. Fertility Surgeries
    • 7.5.1. Hysteroscopy
    • 7.5.2. Laparoscopy
    • 7.5.3. Myomectomy
    • 7.5.4. Varicocele Repair
    • 7.5.5. Varicocelectomy

8. Infertility Treatment Market, by Diagnosis

  • 8.1. Introduction
  • 8.2. Female Infertility
    • 8.2.1. Hysterosalpingography (HSG)
    • 8.2.2. Ovulation Testing
  • 8.3. Male Infertility
    • 8.3.1. Blood Tests
    • 8.3.2. Semen Analysis
    • 8.3.3. Testicular Biopsy

9. Infertility Treatment Market, by End User

  • 9.1. Introduction
  • 9.2. Cryobanks
  • 9.3. Fertility Clinics
  • 9.4. Hospitals
  • 9.5. Research Institutes

10. Americas Infertility Treatment Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Infertility Treatment Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Infertility Treatment Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Bayer enters digital health collaboration with Impli to innovate infertility treatment
    • 13.3.2. Birla Fertility's key acquisition of IVF chain BabyScience signifies a robust expansion in India's growing infertility treatment sector
    • 13.3.3. Conduit Pharmaceuticals boosts portfolio with AstraZeneca's assets to tackle autoimmune disorders and infertility
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Bayer AG
  • 3. City Fertility Centre
  • 4. CooperSurgical, Inc.
  • 5. Cryoport Systems, LLC.
  • 6. Embryolab
  • 7. EQUIPO IVI, S. L.
  • 8. Ferring International Center S.A.
  • 9. FUJIFILM Irvine Scientific, Inc.
  • 10. Genea Group
  • 11. IVI AMERICA, LLC
  • 12. Merck KGaA
  • 13. Monash IVF
  • 14. New Hope Fertility Clinic
  • 15. Nova IVF Fertility
  • 16. NOW-fertility SA
  • 17. Ovum Woman and Child specialty Hospital
  • 18. ReproTech LLC
  • 19. Seegene, Inc.
  • 20. TMRW Life Sciences, Inc.
  • 21. Vitrolife Sweden AB

LIST OF FIGURES

  • FIGURE 1. INFERTILITY TREATMENT MARKET MULTI-CURRENCY
  • FIGURE 2. INFERTILITY TREATMENT MARKET MULTI-LANGUAGE
  • FIGURE 3. INFERTILITY TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 4. INFERTILITY TREATMENT MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL INFERTILITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. INFERTILITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. INFERTILITY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INFERTILITY TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INFERTILITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INFERTILITY TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CRYOSYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY GAS ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY OVUM ASPIRATION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SPERM ANALYZER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SPERM SEPARATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CRYOPRESERVATION MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRACERVICAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRATUBAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY EMBRYO CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION (IVF), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION (ICSI), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PREIMPLANTATION GENETIC DIAGNOSIS (PGD), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CLOMIPHENE CITRATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY GONADOTROPINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LETROZOLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY METFORMIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY HYSTEROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MYOMECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY VARICOCELE REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY VARICOCELECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY HYSTEROSALPINGOGRAPHY (HSG), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY OVULATION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SEMEN ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY TESTICULAR BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CRYOBANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 72. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 74. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 83. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 85. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 86. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 87. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 88. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 89. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 97. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 98. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 99. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 100. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 101. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 107. CANADA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 108. CANADA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 111. CANADA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 112. CANADA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 113. CANADA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 119. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 120. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 121. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 122. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 123. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 124. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 125. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 132. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 154. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 158. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 160. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 162. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. CHINA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. CHINA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 166. CHINA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 167. CHINA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. CHINA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 169. CHINA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 170. CHINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 171. CHINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 172. CHINA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 173. CHINA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 174. CHINA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 175. CHINA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. INDIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. INDIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 178. INDIA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 179. INDIA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. INDIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 181. INDIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 182. INDIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 183. INDIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 184. INDIA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 185. INDIA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 186. INDIA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 187. INDIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 190. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 191. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 193. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 194. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 195. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 196. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 197. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 198. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 199. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 202. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 203. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 205. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 206. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 207. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 208. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 209. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 210. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 211. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 214. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 215. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 217. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 218. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 219. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 220. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 221. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 222. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 223. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 226. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 230. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 232. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 234. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 235. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 238. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 239. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 241. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 242. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 243. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 244. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 245. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 246. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 247. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 254. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 256. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 258. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 259. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 260. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 262. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 263. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 265. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 266. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 267. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 268. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 269. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 270. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 271. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 272. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 274. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 275. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 277. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 278. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 279. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 280. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 281. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 282. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 283. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 284. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 286. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 287. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 289. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 290. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 291. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 292. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 293. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 294. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 295. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 309. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 311. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 312. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 313. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 314. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY (ART), 2018-2030 (USD MILLION)
  • TABLE 315. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 316. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 317. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 318. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 319. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY, 2018-2030 (USD MILLION)
  • TABLE 320. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 321. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 322. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-